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INTRODUCTION
Due to limited health resources and an increase in the
cost of health management, prognosis from the disease
has become a very important area of health sciences.1
Assessment of medical treatment outcome was started
in 1863. Florence Nightingale was the first person who
addressed this issue.2 Many scoring systems have been
developed for intensive care units. These scoring
systems provide gross estimate of mortality risks in
intensive care units patients. The most frequently used
scoring systems are, APACHE-II (acute physiology and
chronic health evaluation II), APACHE-III (acute
physiology and chronic health evaluation III), SAPS II
(simplified acute physiological score II) and MPM II
(mortality probability model II).3,4
The APACHE-II and III scoring systems were developed
by Knaus et al. in 1985 and 1991 respectively.2,4 The
APACHE-II score consists of three components
(Table I). Acute physiology score (APS), the largest
component of the APACHE-II score is derived from 12
clinical measurements that are obtained within 24
hours after admission to the ICU. The most abnormal
measurement is selected to generate the APS
component of the APACHE-II score. If variable has not
been measured, it is assigned zero points. The variables
are, internal temperature, heart rate, mean arterial
pressure, respiratory rate, oxygenation, arterial pH,
serum sodium, serum potassium, serum creatinin,
haematocrit, white blood cells count and Glasgow coma
scale. Second component is age adjustment:  From one
to six points are added for patients older than 44 years
of age. Third component of APACHE-II is chronic health
evaluation. An additional adjustment is made for patients
with severe and chronic organ failure involving the heart,
lungs, kidneys, liver and immune system. 
One of the limitations of these scoring systems is that
these systems basically reflect the population
characteristics and the medical culture of the country in
which they were originally developed.5 Same problem
exists with APACHE-II. So before the application of
these scoring systems they should be tested in the local
medical environment. Literature available on this subject
in Pakistani context is very limited. This study was
designed to correlate the APACHE-II scoring system
with mortality and length of stay in patients admitted in
intensive care unit.
METHODOLOGY
This study was conducted in a 10-bed, general intensive
care unit, at the Aga Khan University Hospital, Karachi,
using a multidisciplinary approach to patient care. 
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ORIGINAL ARTICLE
After approval by the institutional Research Ethics
Committee, study was prospectively carried out  from
10th May 2005 to 10 May 2006. All admitted medical
and surgical (non-cardiac) patients aged 12 years or
above who remained in the intensive care unit for more
than 24 hours, were included in the study. Patients with
incomplete set of physiological variables, post - CABG
patients and patients who stayed for less than 24 hours
in the ICU were excluded. Demographic data, indication
of ICU admission and presence or absence of any
chronic illness was recorded on a data collection form.
At the completion of first 24 hours after the admission in
the ICU, APACHE-II score was calculated by using 12
physiological variables. Points were allocated to the
worst values of each variable as per protocol of
APACHE-II scoring system calculation. Age and chronic
health were also assigned points in the similar manner.
Sum of A, B and C constituted APACHE-II score for a
patient. Glasgow coma scale was used to assess the
conscious levels. In post-surgical patients, who were still
under the effect of anaesthesia, assessment was made
after the patient had overcome the anaesthetic effects.
For intubated patients, this score was calculated
considering their ability to understand, regardless of
speech. Final outcome of the patient (shift out or death)
and total length of ICU stay was also recorded. All the
data recorded on a proforma of APACHE-II score by the
primary investigator.
Statistical analysis was performed through SPSS
version-10.0. Numeric response variables including age
and length of ICU stay were presented as mean ± SD.
All categorical variables including APACHE-II score, age
groups and outcome in terms of either death or
discharge were presented by frequencies and
percentages; chi-square test was applied to compute
significance of association of APACHE-II score and age
with patients' outcome. Pearson's correlation coefficient
was computed to determine correlation of APACHE-II
with age and length of hospital stay. A p-value of less
than 0.05 was considered statistically significant.
RESULTS
Two hundred and fifty three patients were included in the
study; 124 were males and 129 were females. One
hundred and thirty five patients had non-surgical
indications for ICU admission and 118 had surgical
indications for ICU admission. Average age of study
patients was 51.26  ± 17.9 (ranging from 15 to 84 years).
Eighty nine patients were aged under 45 years. Out of
those 89 patients majority (67.4%) survived and were
discharged from the ICU. On the other hand, 71 patients
aged above 64 years, out of whom 25 (35.2%) survived
while 46 (64.8%) died. Significant association (p=0.001)
of age with outcome was therefore revealed (Figure 1).
Mean APACHE-II score of the study patients was 20.84.
On the basis of APACHE-II score, the patients were
divided into five groups. The first group patients had
APACHE-II score of 3-10, second group had 11-20,
third group had 21-30, fourth group had 31-40 and fifth
group scored > 40. 
In the first group, there were 30 patients. Out of them, 27
(90%) were discharged and 3 died (10%). There were
100 patients in second group; 71 (71%) were
discharged and 29 (29%) died. Eighty three patients
were in group III, 33 patients (39%) were discharged,
while 50 patients (61%) died. Group IV had 39 patients;
33 (84.6%) died and only 6 (15.4%) survived. There was
only one patient in group V, with APACHE II score of
> 40, and he died (100%). This revealed that there might
be more chances of death in case of high APACHE-II
score (p=0.001, and more chances of getting out from
the ICU in case of low APACHE scores (Table II,
Figure 2). Mean ICU stay in the patients who expired
was 6.65 (± 4.76 ranging from 1 to 20) days while in
those who survived and discharged was 7.34 (±7.01
ranging from 1 to 51) days. This revealed insignificant
difference of mean ICU stay between the expired and
alive patients (p = 0.365). Insignificant but an inverse
correlation (r = -0.084, p < 0.183) was observed between
APACHE-II score and length of ICU stay.
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Table I: APACHE-II score and patient's outcome (n=253).
APACHE II score Number of patients Patients discharged Patients died Observed mortality (%) Predicted mortality (%)
3-10 30 27 3 10% 11%
11-20 100 71 29 29% 35.5%
21-30 83 33 50 61% 70.3%
31-40 39 6 33 84.6% 91%
>  40 1 0 1 100% 92%
Figure 1: Association of age with outcome (n = 253).
Significant association between higher age and expiry of patients
(χ2 = 17.28, p=0.002).
DISCUSSION
Prediction of patient prognosis admitted in intensive
care unit always remains an area of great concern for
physicians as well as for patient's families. The impact of
this prediction bears on different aspects of patient care
like selection of medical therapy, triaging, end of life care
and many more. The APACHE-II scoring system has
been widely accepted as a measure of illness severity. It
has been shown to accurately stratify risk of death in a
wide range of disease states, and in different clinical
settings.6 In a recently published study, APACHE-II
score found more accurate that trauma score to predict
mortality in trauma patients as well.7 Although APACHE-
II, mortality probability model II, and simplified acute
physiology score II appear to correlate well to different
environments, but it is not always true. A multicenter
study of 26 British and Irish intensive care units
demonstrated the potential limitations of APACHE-II
scoring system when applied to a population for which
the score has not been validated.7,8 These limitations
arise due to different health care facilities and the
variations in the patient population studied. There has
been a very limited use of this scoring system in
Pakistan. No study was found which addressed the
validity of this scoring system in Pakistani population. So
it is very important to check its validity in the local
population.
Average age of the  patients in the current study was
51.26 (±17.9 ranging from 15 to 84) years, which is
comparable with 50 (±19 ranging from 13 to 91) years,
reported from Brazil, 53 (±19.5) reported from
Hong Kong and 56 (±15.9) from Netherland.9-11
Increasing age is known to be associated with mortality
and poor outcome. Mahul and colleagues analyzed the
outcome of 295 ICU patients > 70 years of age.12 They
found that age along with previous health status had a
predictive value. In the current study significant
(p=0.001) association between age with outcome was
observed. Patients above 65 years of age not only had
a significantly higher (p < 0.01) mean APACHE-II score
19.90 (±8.13) than younger age 12.48 (± 7.00), but also
had a higher observed (p < 0.01) and predicted (p > 0.05)
mortality. 
The patient's distribution in the APACHE-II score
intervals showed the highest concentration in the
second group (11-30), which is comparable with other
studies on this subject. Distribution of patients in first
group (3-10) was found significantly low (11.8%) as
compared to report from America.13 Mean APACHE-II
score recorded in this study was 20.84, which is similar
with mean score of 20 reported from Hong Kong, but
higher than 10.7 and 16.5 reported from United States,
16.1 from France, 14.2 from New Zealand  and 12.87
reported from India.9,13,16 These results indicate that the
patients were more severely ill at the time of admission
in the ICU. One reason of high APACHE-II score
observed is the restricted institutional admission policy
due to limited ICU beds. The percentage of intensive
care unit beds in relation to total number of hospital beds
was 1.8%, which is less than other countries, especially
the United States of America,14 where the APACHE-II
system was developed. At the time of study by Knaus
et al., the percentage of intensive care unit beds in
United States of America was 5.6%,14 and this was
increased to 10% by 1992,15 In Europe this percentage
ranged from 2.06% to 3.8%, and in Japan it is 2%.17
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Figure 2: Relationship of APACHE-II score with the outcome of the patients
(n = 253).
*Significant relationship between outcome and APACHE-II score (χ2 = 58.7,
p=0.001).
Table II: APACHE-II scoring system.
+4 -3 -2 -1 +1 -2 +3 -4
Temperature > 41 39-40.9 - 38.5-38.9 36-38.4 34-35.9 32-33.9 30-31.9 < 29.9
MAP > 160 130-159 110-129 - 70-109 - 50-69 < 49
HR > 180 140-179 110-139 - 70-109 - 55-69 40-54 < 39
RR > 50 35-49 - 25-34 12-24 10-11 6-9 - < 5
Oxygenation* > 500 350-499 200-349 - < 200 Pa02 >70 61-70 - 55-60 < 55
pH > 7.7 7.6-7.69 - 7.5-7.59 7.33-7.49 - 7.25-7.32 7.15-7.24 < 7.15
Na- > 180 160-179 155-159 150-154 130-149 - 120-129 111-119 < 110
K- > 7 6.6-6.9 - 5.5-5.9 3.5-5.4 3-3.4 2.5-2.9 - < 2.5
Creat - - - - - - - - -
Hct > 60 - 50-59.9 46-49.9 30-45.9 - 20-29.9 - < 20
WCC > 40 - 20-39.9 15-19.9 3-14.9 - 1-2.9 - .1
15-GCS - - - - - - - - -
* F1O2 > 0.5 record oA-aO2         F1O2 < 0.5 record Pao2
- Plus points for: 1. age > 44 years,  2. chronic health status.
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Overall mortality in this study was 54.2% which is
significantly higher than (8.9% to 38.3%) reported from
various parts of the world.13,18-20
APACHE-II score more than 40 indicates a very high
probability of death in the initial 27-72 hours.6 Results of
our study also show a meaningful association between
APACHE-II score and the risk of mortality. In each
successive APACHE-II score interval the mortality rates
were higher than that of the preceding interval. Our
findings are comparable with Knaus et al.13 and study
from Brazil.10 These findings confirmed the capability of
this scoring system to stratify patients according to the
degree of severity of their disease. Our results showed
good correlation between observed and predicted
mortality. In group 1 patients with APACHE-II score of
3-10, observed mortality was (10%), while predicted
mortality was (11%). In next group, APACHE-II score of
11-20, observed mortality was (29%), while expected
mortality was (35.50%). Similarly observed mortality
was (61%) and (84.6%) in patients with APACHE score
21-30 and 31-40 respectively. Predicted mortality in
these groups were (70.3%) and (91%) respectively.
These results showed slightly over estimation of
mortality risk by APACHE-II scoring system in our
population, especially in higher ranges of APACHE-II.
Our results contradict the results reported from Brazilian
intensive care unit.
ICU length of stay is the most important determinant of
ICU cost and resource utilization. In this study, mean
ICU stay in the patients who expired was 6.65 (±4.76
ranging from 1 to 20) days while in those who survived
and discharged was 7.34 (±7.01 ranging from 1 to 51)
days. This revealed insignificant difference of mean ICU
stay between expired and alive patients (p < 0.365).
In a similar study from Hong Kong,10 the average ICU
stay was 4.2 days, which is less than our findings.
Insignificant but an inverse correlation (r=-0.084,
p < 0.183) was observed between APACHE-II score and
length of ICU stay. 
Results of this study showed that, APACHE-II is capable
of stratifying patient according to disease severity in
relation to mortality. It had good discriminating power for
distinguishing patients who survived from those who
died. But APACHE-II was not sensitive, specific and
accurate enough to predict the patient's exact mortality.
Similarly, it was not accurate enough to predict the
patient's individual mortality.
CONCLUSION
Results of this study show usefulness of APACHE-II
scoring system to classify patients according to their
disease severity. The higher the APACHE-II score was,
higher the risk of mortality.
Disclosure: This is a dissertation-based article.
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